The groundbreaking discovery of induced pluripotent stem cells (iPS cells) provides a new source for cell therapy. However, whether the iPS derived functional lineages from different cell origins have different immunogenicity remains unknown. It had been known that the cells isolated from extra-embryonic tissues, such as umbilical cord mesenchymal cells (UMCs), are less immunogenic than other adult lineages such as skin fibroblasts (SFs). In this report, we differentiated iPS cells from human UMCs and SFs into neural progenitor cells (NPCs) and analyzed their immunogenicity. Through co-culture with allologous peripheral blood mononuclear cells (PBMCs), we showed that UMCs were indeed less immunogenic than skin cells to simulate proliferation of PBMCs. Surprisingly, we found that the NPCs differentiated from UMC-iPS cells retained low immunogenicity as the parental UMCs based on the PBMC proliferation assay. In cytotoxic expression assay, reactions in most kinds of immune effector cells showed more perforin and granzyme B expression with SF-NPCs stimulation than that with UMC-NPCs stimulation in PBMC co-culture system, in T cell co-culture system as well. Furthermore, through whole genome expression microarray analysis, we showed that over 70 immune genes, including all members of HLA-I, were expressed at lower levels in NPCs derived from UMC-iPS cells than that from SF-iPS cells. Our results demonstrated a phenomenon that the low immunogenicity of the less immunogenic cells could be retained after cell reprogramming and further differentiation, thus provide a new concept to generate functional lineages with lower immunogenicity for regenerative medicine.
References
[1]
Thomson JA, Itskovitz-Eldor J, Shapiro SS, Waknitz MA, Swiergiel JJ, et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282: 1145–1147.
[2]
Odorico JS, Kaufman DS, Thomson JA (2001) Multilineage differentiation from human embryonic stem cell lines. Stem Cells 19: 193–204.
[3]
Xi J, Khalil M, Spitkovsky D, Hannes T, Pfannkuche K, et al. (2011) Fibroblasts support functional integration of purified embryonic stem cell-derived cardiomyocytes into avital myocardial tissue. Stem Cells Dev 20: 821–830.
[4]
Lu SJ, Feng Q, Caballero S, Chen Y, Moore MA, et al. (2007) Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods 4: 501–509.
[5]
Kriks S, Shim JW, Piao J, Ganat YM, Wakeman DR, et al. (2011) Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease. Nature 480: 547–551.
[6]
Daadi MM, Grueter BA, Malenka RC, Redmond DE Jr, Steinberg GK (2012) Dopaminergic neurons from midbrain-specified human embryonic stem cell-derived neural stem cells engrafted in a monkey model of Parkinson's disease. PLoS One 7: e41120.
[7]
Niapour A, Karamali F, Nemati S, Taghipour Z, Mardani M, et al. (2012) Cotransplantation of human embryonic stem cell-derived neural progenitors and schwann cells in a rat spinal cord contusion injury model elicits a distinct neurogenesis and functional recovery. Cell Transplant 21: 827–843.
[8]
Falsini B, Bisti S (2012) Embryonic stem-cell-derived retinal pigment epithelial cells for macular degeneration. Lancet 379: 2050; author reply 2050–2051.
[9]
Huang J, McAlinden C, Wang Q, Jin ZB, Pesudovs K (2012) Embryonic stem-cell-derived retinal pigment epithelial cells for macular degeneration. Lancet 379: 2050; author reply 2050–2051.
[10]
Takahashi K, Yamanaka S (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663–676.
[11]
Maherali N, Sridharan R, Xie W, Utikal J, Eminli S, et al. (2007) Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 1: 55–70.
[12]
Zhao Q, Ren H, Li X, Chen Z, Zhang X, et al. (2009) Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells. Cytotherapy 11: 414–426.
[13]
Zhao T, Zhang ZN, Rong Z, Xu Y (2011) Immunogenicity of induced pluripotent stem cells. Nature 474: 212–215.
[14]
Zhao XY, Li W, Lv Z, Liu L, Tong M, et al. (2009) iPS cells produce viable mice through tetraploid complementation. Nature 461: 86–90.
[15]
Cai J, Li W, Su H, Qin D, Yang J, et al. (2010) Generation of human induced pluripotent stem cells from umbilical cord matrix and amniotic membrane mesenchymal cells. J Biol Chem 285: 11227–11234.
[16]
Esteban MA, Wang T, Qin B, Yang J, Qin D, et al. (2010) Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 6: 71–79.
[17]
Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, et al. (2008) Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol 26: 1276–1284.
[18]
Park JK, Kim HS, Uh KJ, Choi KH, Kim HM, et al. (2013) Primed pluripotent cell lines derived from various embryonic origins and somatic cells in pig. PLoS One 8: e52481.
[19]
Wunderlich S, Haase A, Merkert S, Beier J, Schwanke K, et al. (2012) Induction of Pluripotent Stem Cells from a Cynomolgus Monkey Using a Polycistronic Simian Immunodeficiency Virus-Based Vector, Differentiation Toward Functional Cardiomyocytes, and Generation of Stably Expressing Reporter Lines. Cellular Reprogramming 14: 471–484.
[20]
Liskovykh M, Chuykin I, Ranjan A, Safina D, Popova E, et al. (2011) Derivation, characterization, and stable transfection of induced pluripotent stem cells from Fischer344 rats. PLoS One 6: e27345.
[21]
Nelson TJ, Martinez-Fernandez A, Terzic A (2010) Induced pluripotent stem cells: developmental biology to regenerative medicine. Nat Rev Cardiol 7: 700–710.
[22]
Lee G, Studer L (2010) Induced pluripotent stem cell technology for the study of human disease. Nat Methods 7: 25–27.
[23]
Nishikawa S, Goldstein RA, Nierras CR (2008) The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol 9: 725–729.
[24]
Hargus G, Cooper O, Deleidi M, Levy A, Lee K, et al. (2010) Differentiated Parkinson patient-derived induced pluripotent stem cells grow in the adult rodent brain and reduce motor asymmetry in Parkinsonian rats. Proc Natl Acad Sci U S A 107: 15921–15926.
[25]
Yagi T, Kosakai A, Ito D, Okada Y, Akamatsu W, et al. (2012) Establishment of induced pluripotent stem cells from centenarians for neurodegenerative disease research. PLoS One 7: e41572.
[26]
Wang Y, Zheng CG, Jiang Y, Zhang J, Chen J, et al. (2012) Genetic correction of beta-thalassemia patient-specific iPS cells and its use in improving hemoglobin production in irradiated SCID mice. Cell Res 22: 637–648.
[27]
Sebastiano V, Maeder ML, Angstman JF, Haddad B, Khayter C, et al. (2011) In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases. Stem Cells 29: 1717–1726.
[28]
Fairchild PJ (2010) The challenge of immunogenicity in the quest for induced pluripotency. Nat Rev Immunol 10: 868–875.
[29]
Okita K, Nagata N, Yamanaka S (2011) Immunogenicity of induced pluripotent stem cells. Circ Res 109: 720–721.
[30]
Boyd AS, Wood KJ (2010) Characteristics of the early immune response following transplantation of mouse ES cell derived insulin-producing cell clusters. PLoS One 5: e10965.
[31]
Bonde S, Chan KM, Zavazava N (2008) ES-cell derived hematopoietic cells induce transplantation tolerance. PLoS One 3: e3212.
[32]
Robertson NJ, Brook FA, Gardner RL, Cobbold SP, Waldmann H, et al. (2007) Embryonic stem cell-derived tissues are immunogenic but their inherent immune privilege promotes the induction of tolerance. Proc Natl Acad Sci U S A 104: 20920–20925.
[33]
Drukker M, Katz G, Urbach A, Schuldiner M, Markel G, et al. (2002) Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A 99: 9864–9869.
[34]
Pick M, Ronen D, Yanuka O, Benvenisty N (2012) Reprogramming of the MHC-I and its Regulation by NFkappaB in Human Induced Pluripotent Stem Cells. Stem Cells 30: 2700–2708.
[35]
Suarez-Alvarez B, Rodriguez RM, Calvanese V, Blanco-Gelaz MA, Suhr ST, et al. (2010) Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells. PLoS One 5: e10192.
[36]
Araki R, Uda M, Hoki Y, Sunayama M, Nakamura M, et al. (2013) Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells. Nature 494: 100–104.
[37]
Becker PD, Legrand N, van Geelen CMM, Noerder M, Huntington ND, et al. (2010) Generation of Human Antigen-Specific Monoclonal IgM Antibodies Using Vaccinated “Human Immune System” Mice. Plos One 5: e13137.
[38]
Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, et al. (2011) A more efficient method to generate integration-free human iPS cells. Nat Methods 8: 409–412.
[39]
Kadereit S, Trounson A (2011) In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages. Semin Immunopathol 33: 551–562.
[40]
Wang M, Yang Y, Yang D, Luo F, Liang W, et al. (2009) The immunomodulatory activity of human umbilical cord blood-derived mesenchymal stem cells in vitro. Immunology 126: 220–232.
[41]
Prasanna SJ, Gopalakrishnan D, Shankar SR, Vasandan AB (2010) Pro-inflammatory cytokines, IFNgamma and TNFalpha, influence immune properties of human bone marrow and Wharton jelly mesenchymal stem cells differentially. PLoS One 5: e9016.
[42]
Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, et al. (2008) Immune properties of human umbilical cord Wharton's jelly-derived cells. Stem Cells 26: 2865–2874.
[43]
Strachan T, Read AP (2004). Human Molecular Genetics. 3nd ed. New York.
[44]
Yang J, Cai J, Zhang Y, Wang X, Li W, et al. (2010) Induced pluripotent stem cells can be used to model the genomic imprinting disorder Prader-Willi syndrome. J Biol Chem 285: 40303–40311.
[45]
Kim DS, Lee JS, Leem JW, Huh YJ, Kim JY, et al. (2010) Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity. Stem Cell Rev 6: 270–281.
[46]
Ghose J, Sinha M, Das E, Jana NR, Bhattacharyya NP (2011) Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease. PLoS One 6: e23837.
[47]
Takata H, Tomizawa K, Matsushita M, Matsui H (2004) 2-methoxyestradiol enhances p53 protein transduction therapy-associated inhibition of the proliferation of oral cancer cells through the suppression of NFkappaB activity. Acta Med Okayama 58: 181–187.
[48]
Duffy MM, Ritter T, Ceredig R, Griffin MD (2011) Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Res Ther 2: 34.
[49]
Moretta L, Locatelli F, Pende D, Marcenaro E, Mingari MC, et al. (2011) Killer Ig-like receptor-mediated control of natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation. Blood 117: 764–771.
[50]
Wang L, Hong B, Jiang X, Jones L, Chen SY, et al. (2012) A20 controls macrophage to elicit potent cytotoxic CD4(+) T cell response. PLoS One 7: e48930.
[51]
Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, et al. (2013) Combined TLR2/4-Activated Dendritic/Tumor Cell Fusions Induce Augmented Cytotoxic T Lymphocytes. PLoS One 8: e59280.
[52]
Sindhu ST, Ahmad R, Morisset R, Ahmad A, Menezes J (2003) Peripheral blood cytotoxic gammadelta T lymphocytes from patients with human immunodeficiency virus type 1 infection and AIDS lyse uninfected CD4+ T cells, and their cytocidal potential correlates with viral load. J Virol 77: 1848–1855.
[53]
Zhou W, Sharma M, Martinez J, Srivastava T, Diamond DJ, et al. (2007) Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Viral Immunol 20: 379–388.
[54]
Quezada SA, Simpson TR, Peggs KS, Merghoub T, Vider J, et al. (2010) Tumor-reactive CD4(+) T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts. J Exp Med 207: 637–650.
[55]
Xie Y, Akpinarli A, Maris C, Hipkiss EL, Lane M, et al. (2010) Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma. J Exp Med 207: 651–667.
[56]
Kim K, Doi A, Wen B, Ng K, Zhao R, et al. (2010) Epigenetic memory in induced pluripotent stem cells. Nature 467: 285–290.
[57]
Bar-Nur O, Russ HA, Efrat S, Benvenisty N (2011) Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells. Cell Stem Cell 9: 17–23.
[58]
Ohi Y, Qin H, Hong C, Blouin L, Polo JM, et al. (2011) Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 13: 541–549.
[59]
Charron D, Suberbielle-Boissel C, Al-Daccak R (2009) Immunogenicity and allogenicity: a challenge of stem cell therapy. J Cardiovasc Transl Res 2: 130–138.
[60]
Boyd AS, Rodrigues NP, Lui KO, Fu X, Xu Y (2012) Concise review: Immune recognition of induced pluripotent stem cells. Stem Cells 30: 797–803.
[61]
Li B, Xu L, Lu WY, Xu W, Wang MH, et al. (2010) A whole-mechanical method to establish human embryonic stem cell line HN4 from discarded embryos. Cytotechnology 62: 509–518.
[62]
Almici C, Carlo-Stella C, Mangoni L, Garau D, Cottafavi L, et al. (1995) Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking. Stem Cells 13: 533–540.
[63]
Almici C, Carlo-Stella C, Wagner JE, Rizzoli V (1995) Umbilical cord blood as a source of hematopoietic stem cells: from research to clinical application. Haematologica 80: 473–479.
[64]
Wagner JE, Collins D, Fuller S, Schain LR, Berson AE, et al. (1995) Isolation of small, primitive human hematopoietic stem cells: distribution of cell surface cytokine receptors and growth in SCID-Hu mice. Blood 86: 512–523.
[65]
Farowski F, Cornely OA, Vehreschild JJ, Bauer T, Hartmann P, et al. (2012) Intracellular concentrations of micafungin in different cellular compartments of the peripheral blood. Int J Antimicrob Agents 39: 228–231.
[66]
Jangpatarapongsa K, Xia H, Fang Q, Hu K, Yuan Y, et al. (2012) Immunity to malaria in Plasmodium vivax infection: a study in central China. PLoS One 7: e45971.
